CA
AGN

Commerzbank Aktiengesellschaft’s Allergan plc AGN Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-117,900
Closed -$1.07M – 1066
2019
Q2 		$1.07M Buy
+117,900
New +$16.3M 0.01% 596
2019
Q1 		– Sell
-97,500
Closed -$2.71M – 1009
2018
Q4 		$2.71M Buy
97,500
+45,100
+86% +$7.39M 0.03% 362
2018
Q3 		$192K Buy
52,400
+41,900
+399% +$7.7M ﹤0.01% 888
2018
Q2 		$156K Buy
+10,500
New +$1.69M ﹤0.01% 856

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Commerzbank Aktiengesellschaft's AGN Position: Q2 2020 in Review

Commerzbank Aktiengesellschaft sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 71,870 shares — an estimated $12.7M sold.

Commerzbank Aktiengesellschaft first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $49.1M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 71,870 Allergan plc shares in Q2 2020, an estimated $12.7M.
  • Commerzbank Aktiengesellschaft first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Commerzbank Aktiengesellschaft's Allergan plc position peaked at $49.1M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2020, filed 21 Jul 2020.